Literature DB >> 31076120

Integrated Treatment of Adolescents with Co-occurring Depression and Substance Use Disorder.

Jesse D Hinckley1, Paula Riggs2.   

Abstract

Substance use disorders (SUDs) are commonly co-occurring among adolescents with depression. Integrated treatment is important given treatment implications and increased rates of suicidality. All adolescents should be screened for SUD using Screening, Brief Intervention, and Referral to Treatment. Review of randomized controlled trials in adolescents reveals motivational enhancement therapy/cognitive behavioral therapy is an evidence-based intervention and should be considered first-line treatment. If depression does not improve, fluoxetine should be considered, as it is well-tolerated in substance-involved adolescents with depression. Adolescents who do not show improvement in SUD or who have severe SUD should be referred to evidence-based SUD treatment.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescents; Co-occurring disorders; Fluoxetine; MET/CBT; Motivational interviewing; SBIRT; Substance use disorders

Mesh:

Substances:

Year:  2019        PMID: 31076120     DOI: 10.1016/j.chc.2019.02.006

Source DB:  PubMed          Journal:  Child Adolesc Psychiatr Clin N Am        ISSN: 1056-4993


  3 in total

1.  Addressing adolescent substance use in an urban pediatric federally qualified health center.

Authors:  Juliet C Yonek; Sarah Velez; Derek D Satre; Kathryn Margolis; Amy Whittle; Shonul Jain; Marina Tolou-Shams
Journal:  J Subst Abuse Treat       Date:  2021-10-28

2.  Toward a New Model of Understanding, Preventing, and Treating Adolescent Depression Focusing on Exhaustion and Stress.

Authors:  Toon van der Gronde; Leontien Los; Arnoud Herremans; Ronald Oosting; Rafaela Zorzanelli; Toine Pieters
Journal:  Front Psychiatry       Date:  2020-05-06       Impact factor: 4.157

3.  Trends and Disparities in Treatment for Co-occurring Major Depression and Substance Use Disorders Among US Adolescents From 2011 to 2019.

Authors:  Wenhua Lu; Miguel Muñoz-Laboy; Nancy Sohler; Renee D Goodwin
Journal:  JAMA Netw Open       Date:  2021-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.